Cart
sales@molnova.com
Home - Products - Angiogenesis - CDK - 4-Methoxybenzoic acid

4-Methoxybenzoic acid

CAS No. 100-09-4

4-Methoxybenzoic acid( p-Anisic acid | NSC 32742 )

Catalog No. M17742 CAS No. 100-09-4

4-Methoxybenzoic acid could be used as raw material in cosmetic and dermatologic products and/or aroma components in foodstuffs, it has antiinflammatory and antimicrobial activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 41 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    4-Methoxybenzoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Methoxybenzoic acid could be used as raw material in cosmetic and dermatologic products and/or aroma components in foodstuffs, it has antiinflammatory and antimicrobial activities.
  • Description
    p-Anisic acid, also known as 4-methoxybenzoic acid or draconic acid, is one of the isomers of anisic acid. The term "anisic acid" often refers to this form specifically. p-Anisic acid is found naturally in anise.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    p-Anisic acid | NSC 32742
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100-09-4
  • Formula Weight
    152.14
  • Molecular Formula
    C8H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (657.25 mM)
  • SMILES
    COC1=CC=C(C=C1)C(=O)O
  • Chemical Name
    Benzoic acid, 4-methoxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • CDK4-IN-1

    CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM.

  • BML-259

    BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.

  • FN-1501

    FN-1501 is a potent FLT3 and CDK inhibitor (IC50s: 2.47, 0.85, 1.96, and 0.28 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK6/cyclin D1 and FLT3, respectively).

Sign In Join Free